1 3
Topics in Current Chemistry (2020) 378:15
Fig. 10
In vivo drug-conjugated SWCNT therapeutic efficacy assessed using BLI and MRI:
a schematic diagram illustrating the functionalized SWCNTs as theranostic
carriers,
b representative bioluminescence images,
c representative axial MR images, and
d quantitative measurements of tumor volume in MDA-MB-231 tumor-bearing
mice. Imaging protocols were performed pre- (t = 0) and up to 35 days post-treatment (modified with permission from Al Faraj et al. [192])
201
Reprinted from the journal
Topics in Current Chemistry (2020) 378:15
Fig. 10
In vivo drug-conjugated SWCNT therapeutic efficacy assessed using BLI and MRI:
a schematic diagram illustrating the functionalized SWCNTs as theranostic
carriers,
b representative bioluminescence images,
c representative axial MR images, and
d quantitative measurements of tumor volume in MDA-MB-231 tumor-bearing
mice. Imaging protocols were performed pre- (t = 0) and up to 35 days post-treatment (modified with permission from Al Faraj et al. [192])
201
Reprinted from the journal
